Stockreport

Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg

Alvotech - Ordinary Shares  (ALVO) 
PDF REYKJAVIK, Iceland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosim [Read more]